Korsuva Injection, Solution
Product Images NDC 59353-065

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Korsuva (NDC 59353-065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vifor (international), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mech 46870 C Korsuva Carton Us V20

KORSUVA (difelikefalin) Injection is a prescription drug with a dosage of 2mg. The provided text contains some medical jargon with minimal information on the usage of the drug. The text does not provide any significant information on the indications and side effects of the drug.*

FDA Label Image

Difelikefalin Acetate Chemical Structure (Image 01)

FDA Label Image

Figure 1: Percentage Of Subjects With Moderate-to-severe Ckd-ap Undergoing Hd With A ≥4-point Improvement From Baseline On The Wi-nrs In Trial 1 And Trial 2 (Image 02)

The text provides the percentages of subjects in two different clinical trials, one with KORSUVA and placebo and the other with only KORSUVA, but no additional information is available.*

FDA Label Image

Korsuva (difelikefalin injection, solution)

This appears to be a medication label for an injection called "BKORSUVA B" (difelikefalin). The label includes storage instructions and dosage information. The manufacturer is listed as Cara Therapeutics, with a location in Stamford, CT and the product is made in France. However, the lot number and expiration date are not readable, so they are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.